Chief Executive Officer
Dale Fox is Co-Founder and Chief Executive Officer (CEO) of Tribogenics and serves on its Board of Directors. At Tribogenics, Dale leads an experienced global leadership team that is focused on bringing to market breakthrough X-ray technology that will reshape the $20 billion global X-ray industry.
Dale is a seasoned start-up entrepreneur and inventor with 20+ year track record of converting technology innovation into sustainable revenue growth across multiple businesses. He has grown technology companies in the USA and overseas, launching more than two dozen successful products in both software and hardware arenas. He’s has built world-class executive and advisory teams, and raised numerous rounds of funding to drive profitability and exceed investor goals.
In 2015, Dale will spearhead the launch of Tribogenics’ first commercial products – the Watson™ family of handheld XRF analyzers. Initially, it will provide nondestructive elemental analysis of all metal alloys for positive material identification (PMI), scrap metal, recycling, and manufacturing, achieving this at one tenth of the cost of conventional technologies.
When he’s not growing organizations, Dale is helping to develop and support the next generation of entrepreneurs and innovators. He currently mentors young entrepreneurs at a handful of promising early-stage companies.
PhD, Co-Founder and Chief Scientist
Carlos Camara is Chief Scientist at Tribogenics. He reports to Chief Executive Officer (CEO) Dale Fox and serves on the Board of Directors. Carlos is a physicist and co-inventor of the company’s innovative X-ray technology. At Tribogenics, he leads a diverse team of scientists and engineers to explore and evolve the company’s disruptive technology for application areas that include positive materials identification, manufacturing, recycling, mining, medical, oil, and gas.
Previously, he served as Scientist and Post Doctorate Scholar at UCLA. It was here that his work studying energy focusing phenomena and triboluminescence spawned the discovery of a new X-ray source.
Carlos’ scientific mind, passion, and commitment to inventing and evolving technology that has a positive impact on society are a driving force on the Tribogenics management team and in the lab. Camara received his Ph.D. from the University of California, Los Angeles (UCLA)
Chief Operating Officer & SVP of Sales
Mark Valentine is Chief Operating Officer (COO) and Senior Vice President of Sales at Tribogenics where he oversees day-to-day operations. He leads the company’s sales strategy, managing its growing global sales teams, distribution, and manufacturers’ representatives around the world.
Before joining Tribogenics, he served as President and COO of a leading medical manufacturing organization. There, he transformed that company into a world-class provider of digital X-ray imaging hardware and software products. He managed rapid growth to more than a hundred employees in multiple offices around the globe and implemented successful sales and distribution agreements with leading organizations. This included a pivotal OEM agreement with GE Medical,and an agreement to supply the United States Military with portable imaging equipment. He also opened up China and India, exporting large quantities of imaging systems to both markets.
From the R&D lab to volume production environments, Valentine is a seasoned executive with 25 years of success in delivering products to market on time. He is an innovative manager, team builder, and entrepreneur who takes immense pride in building effective global sales and customer support operations that drives top line growth.
A principal at Founders Fund, Scott has broad experience in engineering, science and management. He helped develop the propulsion systems and elements of the Dragon spacecraft at Space X, and worked with private equity clients at Bain & Company. Scott graduated with honors from Cornell University, receiving both a BS in Aerospace & Mechanical Engineering and a Master’s in Aerospace Engineering in less than 4 years.
Thomas W. Turney
Thomas currently serves as Managing Principal of NewCap Partners, a private investment banking firm focusing on the corporate finance needs of middle-market companies. Mr. Turney received his BA in Economics from UCLA and holds an MA in Economics and an MBA from the University of Southern California.
Claude D. Benchimol, PhD
Claude is the Founder of Damol Innovation LLC, a consulting practice focused on technology-based innovation in healthcare (medical devices, pharma & biotech, healthcare IT). He has a 35 year success history of building, leading and inspiring vibrant global organizations, responsible for the introduction of medical imaging systems like CT Scanners within GE Healthcare and DNA sequencers within Life Technologies. He is also a member of the French Academy of Technology.
Head of Marketing
Stewart Chalmers is Head of Marketing at Tribogenics. He reports to Mark Valentine, COO. Chalmers is responsible for global marketing strategy. He leads the company’s commercialization effort where he is responsible for positioning Tribogenics and its new Watson™ handheld XRF products. He is a key contributor to growing the sales, marketing, and customer service operations to support growth of the company’s breakthrough new X-ray technology.
Chalmers brings to Tribogenics a deep track record of developing successful global marketing campaigns, building sales and marketing organizations that drive revenue growth. He brings a strong understanding of positioning for media, investor, and strategic communications. And for 18 years, he has designed 23 successful product launches and go-to-market plans that have helped spark growth for a number of start-ups, emerging, and Fortune 500 companies.
Throughout his career, he has worked for, represented and grown a broad range of B2B technology companies in Silicon Valley and overseas, including, semiconductors, energy, banking and payments, medical, and industrial sectors. A native of Scotland, he holds a Bachelor’s of Science degree in International Business from San Jose State University, San Jose, California.
VP of Operations
John Schoeffler is Vice President of Operations at Tribogenics where he oversees the company’s manufacturing operations to support the growing global demand. John leads a dedicated production team responsible for developing the manufacturing processes of the company’s X-ray source technology and assembly of the handheld Watson™ XRF platform.
John is an experienced executive with 21 years of success in delivering high quality products on time. Before joining Tribogenics, he served as a Director of Operational Excellence for of an Aerospace company leading the lean operational efforts across multiple global facilities. There, he transformed that company into a world-class lean provider of electro-mechanical assemblies. Along the way, he spent eleven years in the Automotive industry where he served in a broad range of Operations and Engineering leadership roles committed to delivering leading edge audio infotainment systems. He also played a key leadership role in the start up of greenfield facilities in the US and Mexico throughout his career.
John’s track record in developing new manufacturing operations and launching new products is an enormous benefit to Tribogenics as production ramps through commercialization. He is an innovative leader with a technical background who takes immense pride in building an effective lean operations team. He holds a Mechanical Engineering degree from the University at Buffalo.
Director of Finance
30 years experience
Public and private companies. A financial expert with 30 years experience managing the financial aspects of dynamic organizations, Craig has a track record of success with both start-ups and established businesses. He has held numerous CFO positions and consultant roles with companies in a variety of fields including technology, e-commerce, online media and advertising, and manufacturing and distribution.
Robert is an expert in intellectual property and the architect of the licensing business for Acacia. During his tenure, Acacia entered into over 500 license agreements and increased its market cap from $20 million to over $400 million.
Michael is a Professor of Materials Science at University of California Santa Barbara. His research focuses on printed electronics and polymer films. He received his PhD in chemistry from Stanford University.
An international leader in the commercial space arena, Dr. Diamandis is Chairman and CEO of the X PRIZE Foundation and co-founder & Chairman of Singularity University. Dr. Diamandis received degrees from MIT in molecular genetics and aerospace engineering and holds an MD from Harvard Medical School.
Warren is a Professor of Biomedical Engineering, Electrical Engineering, and Surgery at UCLA. He also serves as a Senior Technology Advisor to TATRC (Telemedicine and Advanced Technology Research Center of the Army) and regularly consults for the NIH and FDA Office of Device Evaluation.
Daniel holds numerous professional and advisory positions including Physician/Scientist at Stanford Medical School, Chair of the Medicine Track at Ray Kurzweil’s Singularity University, Chair of the FutureMed program at NASA/Ames, TED Fellow, Flight Surgeon with the California Air National Guard and a NASA Astronaut Finalist.
Seth is a Professor of Physics at UCLA and led the effort that resulted in the discovery of X-ray emission from triboelectrification. He received a BS from Caltech and a PhD from the Rockefeller University.
Chief Technology Officer
Steve Hansen is Chief Technology Officer at Tribogenics. He reports to Dale Fox, CEO. Steve leads a dedicated team of engineers responsible for developing the company’s X-ray source technology, one of the key enabling technologies behind the new handheld Watson™ XRF platform.
Before joining Tribogenics, Steve served as COO and VP of Engineering for Oraya Therapeutics – a Silicon Valley based start-up that manufactures low energy stereotactic radiation therapy systems for age related macular degeneration. Steve was instrumental in growing and managing the company from incubation through to commercialization in 2013. This included raising $76 million in funding. In addition to Oraya, he has helped grow a number of fledgling technology start-ups, including Xoft, X-Illumina, and Midwest Research Microscopy. Along the way, he spent ten years at GE Electric Medical Systems where he served in a broad range of engineering, research, and operations management roles committed to delivering leading edge X-ray products to market.
Steve’s track record in developing start-ups from concept to commercialization is an enormous benefit to Tribogenics as it expands the reach of its breakthrough X-ray technology. He holds a number of U.S. patents and holds a Masters of Science-Engineering degree from the University of Wisconsin-Milwaukee
Head of Talent
Elizabeth Harlow is Head of Talent at Tribogenics. She leads the company’s human resources functions. Elizabeth plays a key role in recruiting, onboarding, and retaining visionaries and experts in their respective fields. She is also responsible for Tribogenics’ day to day operations such as employee relations, payroll, and information management.
Elizabeth has a track record of supporting companies in periods of rapid growth through the recruitment and retention of top talent. Prior to joining Tribogenics, Elizabeth was at FPT, where she managed recruiting and human resources for the United States. Elizabeth holds a Bachelor of Arts degree in Political Science and Resource Management from Miami University.
William King, PhD
William is a Bliss Prof. Mech. Science & Engineering, Univ. of Illinois, Urbana. PhD, Mech. E, Stanford. Harvard Business School.